Additionally, several animal models of acute respiratory distress syndrome (ARDS) have been successfully treated with MSCs or fibroblasts modified to express angiopoietin 1, a protein that antagonizes vascular inflammation observed in ARDS [230]. The gene discussed is ANGPT1; the disease is acute respiratory distress syndrome.